Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anixa Biosciences

3.23
+0.04001.25%
Post-market: 3.300.0700+2.17%15:57 EDT
Volume:38.26K
Turnover:123.37K
Market Cap:104.04M
PE:-8.56
High:3.39
Open:3.19
Low:3.19
Close:3.19
Loading ...

Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th

PR Newswire
·
03 Mar

Anixa doses first patient in third cohort of Phase 1 clinical trial of CAR-T

TIPRANKS
·
26 Feb

Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial

THOMSON REUTERS
·
26 Feb

Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial

PR Newswire
·
26 Feb

Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"

PR Newswire
·
25 Feb

Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer

PR Newswire
·
24 Feb

Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year?

Zacks
·
21 Feb

Anixa Biosciences Price Target Maintained With a $7.00/Share by HC Wainwright & Co.

Dow Jones
·
19 Feb

H.C. Wainwright Sticks to Its Buy Rating for Anixa Biosciences (ANIX)

TIPRANKS
·
19 Feb

Anixa Biosciences: Advancing CAR-T Therapy and Cancer Vaccines with Strategic Trial Amendments and Robust Financial Position

TIPRANKS
·
19 Feb

Anixa Biosciences announces approval of protocol amendment for CAR-T trial

TIPRANKS
·
18 Feb

Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial

THOMSON REUTERS
·
18 Feb

Anixa Biosciences Inc - Amendment Allows Second Dose and Expands Eligibility in CAR-T Trial

THOMSON REUTERS
·
18 Feb

Director Shows Confidence in Anixa Biosciences with New Stock Purchase

TIPRANKS
·
30 Jan

Anixa Biosciences Inc: With $20 Mln in Cash and Investments, We Have a Cash Runway of Over 2.5 Years

THOMSON REUTERS
·
21 Jan

Anixa Biosciences Leads 3 Promising Penny Stocks On US Exchanges

Simply Wall St.
·
17 Jan

Anixa Biosciences (NASDAQ:ANIX) Is In A Good Position To Deliver On Growth Plans

Simply Wall St.
·
14 Jan